Lv4
508 积分 2024-03-28 加入
Discovery of Reversible Covalent Bruton's Tyrosine Kinase Inhibitors PRN473 and PRN1008 (Rilzabrutinib)
19天前
已完结
Benchmarking Methods for PROTAC Ternary Complex Structure Prediction
2个月前
已完结
Druglike Molecular Degraders of the Oncogenic RNA-Binding Protein HuR
3个月前
已完结
Discovery of a Potent and Selective Tyrosine Kinase 2 Inhibitor: TAK-279
3个月前
已完结
Neuropilin-1-Targeted Cell-Penetrating Tandem Peptide–Drug Conjugate Exhibits Potent In Vivo Antiglioma and Antiangiogenic Activity
5个月前
已完结
Linker Optimization Enhances the Potency of Ribonuclease-Targeting Chimeras in Cancer Models
6个月前
已完结
Aptamer‐RIBOTAC Strategy Enabling Tumor‐Specific Targeted Degradation of MicroRNA for Precise Cancer Therapy
7个月前
已完结
Artificial intelligence in drug development
10个月前
已完结
Structural basis for CaVα2δ:gabapentin binding
11个月前
已完结
皖公网安备34019202002308
